-
1
-
-
53549101290
-
The evolution of our thinking about microRNAs
-
Ambros V. The evolution of our thinking about microRNAs. Nat Med 2008; 14: 1036-40.
-
(2008)
Nat Med
, vol.14
, pp. 1036-1040
-
-
Ambros, V.1
-
2
-
-
77955902024
-
The widespread regulation of microRNA biogenesis, function and decay
-
Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
-
(2010)
Nat Rev Genet
, vol.11
, pp. 597-610
-
-
Krol, J.1
Loedige, I.2
Filipowicz, W.3
-
3
-
-
84934444624
-
MicroRNAs in human cancer
-
Schmitz U, Wolkenhauer O, Vera J, Eds, Advances in Experimental Medicine and Biology 774. Dordrecht: Springer Science-Business Media
-
Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. In: Schmitz U, Wolkenhauer O, Vera J, Eds. MicroRNA Cancer Regulation Advanced Concepts, Bioinformatics and Systems Biology Tools. Advances in Experimental Medicine and Biology 774. Dordrecht: Springer Science-Business Media 2013; pp. 1-20.
-
(2013)
MicroRNA Cancer Regulation Advanced Concepts, Bioinformatics and Systems Biology Tools
, pp. 1-20
-
-
Farazi, T.A.1
Hoell, J.I.2
Morozov, P.3
Tuschl, T.4
-
4
-
-
77953629046
-
Regulation of mRNA translation and stability by microRNAs
-
Fabian MR, Sonemberg N. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351-79.
-
(2010)
Annu Rev Biochem
, vol.79
, pp. 351-379
-
-
Fabian, M.R.1
Sonemberg, N.2
-
5
-
-
78751477191
-
Gene silencing by microRNAs: Contributions of translational repression and mRNA decay
-
Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99-110.
-
(2011)
Nat Rev Genet
, vol.12
, pp. 99-110
-
-
Huntzinger, E.1
Izaurralde, E.2
-
6
-
-
34249282938
-
MicroRNA silencing through RISC recruitment of eIF6
-
Chendrimada TP, Finn KJ, Ji X, et al. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007; 447: 823-8.
-
(2007)
Nature
, vol.447
, pp. 823-828
-
-
Chendrimada, T.P.1
Finn, K.J.2
Ji, X.3
-
7
-
-
37648998629
-
Getting the root of miRNA-mediated gene silencing
-
Eulalio A, Huntzinger E, Izaurralde E. Getting the root of miRNA-mediated gene silencing. Cell 2008; 132: 9-14.
-
(2008)
Cell
, vol.132
, pp. 9-14
-
-
Eulalio, A.1
Huntzinger, E.2
Izaurralde, E.3
-
9
-
-
84861866572
-
The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC
-
Fabian MR, Sonemberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586-93.
-
(2012)
Nat Struct Mol Biol
, vol.19
, pp. 586-593
-
-
Fabian, M.R.1
Sonemberg, N.2
-
10
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
11
-
-
81855224576
-
Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy
-
Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-64.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 849-864
-
-
Kasinski, A.L.1
Slack, F.J.2
-
12
-
-
84858782897
-
Inhibition of microRNA function by antimiR oligonucleotides
-
Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S. Inhibition of microRNA function by antimiR oligonucleotides. Silence 2012; 3: 1.
-
(2012)
Silence
, vol.3
, pp. 1
-
-
Stenvang, J.1
Petri, A.2
Lindow, M.3
Obad, S.4
Kauppinen, S.5
-
13
-
-
18744396337
-
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 15524-15529
-
-
Calin, G.A.1
Dumitru, C.D.2
Shimizu, M.3
-
14
-
-
25444520537
-
miR-15 and miR-16 induce apoptosis by targeting BCL2
-
Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-9.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 13944-13949
-
-
Cimmino, A.1
Calin, G.A.2
Fabbri, M.3
-
15
-
-
70349976210
-
MicroRNAs: Novel regulators in the hallmarks of human cancer
-
Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285: 116-26.
-
(2009)
Cancer Lett
, vol.285
, pp. 116-126
-
-
Ruan, K.1
Fang, X.2
Ouyang, G.3
-
16
-
-
77950843538
-
The dicey role of Dicer: Implications for RNAi therapy
-
Merritt WM, Bar-Eli M, Sood AK. The dicey role of Dicer: implications for RNAi therapy. Cancer Res 2010; 70: 2571-4.
-
(2010)
Cancer Res
, vol.70
, pp. 2571-2574
-
-
Merritt, W.M.1
Bar-Eli, M.2
Sood, A.K.3
-
17
-
-
54249117763
-
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk
-
Chin LJ, Ratner E, Leng S, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008; 68: 8535-40.
-
(2008)
Cancer Res
, vol.68
, pp. 8535-8540
-
-
Chin, L.J.1
Ratner, E.2
Leng, S.3
-
18
-
-
58349104128
-
Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women
-
Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79-84.
-
(2009)
Hum Mutat
, vol.30
, pp. 79-84
-
-
Hu, Z.1
Liang, J.2
Wang, Z.3
-
19
-
-
77953122376
-
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk
-
Yang R, Schlehe B, Hemminki K, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 2010; 121: 693-702.
-
(2010)
Breast Cancer Res Treat
, vol.121
, pp. 693-702
-
-
Yang, R.1
Schlehe, B.2
Hemminki, K.3
-
20
-
-
84876568202
-
Measuring microRNA expression levels in oncology: From samples to data analysis
-
De Cecco L, Dugo M, Canevari S, Daidone MG, Callari M. Measuring microRNA expression levels in oncology: from samples to data analysis. Crit Rev Oncog 2013; 18: 273-87.
-
(2013)
Crit Rev Oncog
, vol.18
, pp. 273-287
-
-
De Cecco, L.1
Dugo, M.2
Canevari, S.3
Daidone, M.G.4
Callari, M.5
-
21
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.G.3
-
22
-
-
84858126071
-
MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review
-
Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-59.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 143-159
-
-
Iorio, M.V.1
Croce, C.M.2
-
23
-
-
84867867438
-
MicroRNA-mediated gene regulations in human sarcomas
-
Subramanian S, Kartha RV. MicroRNA-mediated gene regulations in human sarcomas. Cell Mol Life Sci 2012; 69: 3571-85.
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 3571-3585
-
-
Subramanian, S.1
Kartha, R.V.2
-
24
-
-
33644819964
-
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
-
Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-98.
-
(2006)
Cancer Cell
, vol.9
, pp. 189-198
-
-
Yanaihara, N.1
Caplen, N.2
Bowman, E.3
-
25
-
-
70349871321
-
MicroRNA expression, survival, and response to interferon in liver cancer
-
Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-47.
-
(2009)
N Engl J Med
, vol.361
, pp. 1437-1447
-
-
Ji, J.1
Shi, J.2
Budhu, A.3
-
26
-
-
77954378366
-
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression
-
Zhou M, Liu Z, Zhao Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 2010; 285: 21496-507.
-
(2010)
J Biol Chem
, vol.285
, pp. 21496-21507
-
-
Zhou, M.1
Liu, Z.2
Zhao, Y.3
-
27
-
-
77953169001
-
MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
-
Giovannetti E, Funel N, Peters GJ, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010; 70: 4528-38.
-
(2010)
Cancer Res
, vol.70
, pp. 4528-4538
-
-
Giovannetti, E.1
Funel, N.2
Peters, G.J.3
-
28
-
-
84878573162
-
Circulating microRNAs as potential new biomarkers for prostate cancer
-
Sita-Lumsden A, Dart DA, Waxman J, Bevan CL. Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer 2013; 108: 1925-30.
-
(2013)
Br J Cancer
, vol.108
, pp. 1925-1930
-
-
Sita-Lumsden, A.1
Dart, D.A.2
Waxman, J.3
Bevan, C.L.4
-
30
-
-
76949085030
-
miR-21: An oncomir on strike in prostate cancer
-
Folini M, Gandellini P, Longoni N, et al. miR-21: an oncomir on strike in prostate cancer. Mol Cancer 2010; 9: 12.
-
(2010)
Mol Cancer
, vol.9
, pp. 12
-
-
Folini, M.1
Gandellini, P.2
Longoni, N.3
-
31
-
-
84877922897
-
MicroRNAs in the ionizing radiation response and in radiotherapy
-
Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev 2013; 23: 12-9.
-
(2013)
Curr Opin Genet Dev
, vol.23
, pp. 12-19
-
-
Metheetrairut, C.1
Slack, F.J.2
-
32
-
-
78650491562
-
Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics
-
Allen KE, Weiss GJ. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 2010; 9: 3126-36.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 3126-3136
-
-
Allen, K.E.1
Weiss, G.J.2
-
33
-
-
80052391165
-
miRNA response to DNA damage
-
Wan G, Mathur R, Hu X, Zhang X, Lu X. miRNA response to DNA damage. Trends Biochem Sci 2011; 36: 478-84.
-
(2011)
Trends Biochem Sci
, vol.36
, pp. 478-484
-
-
Wan, G.1
Mathur, R.2
Hu, X.3
Zhang, X.4
Lu, X.5
-
35
-
-
0005772676
-
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide
-
Stephenson ML, Zamecnik PC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc Natl Acad Sci USA 1978; 75: 285-8.
-
(1978)
Proc Natl Acad Sci USA
, vol.75
, pp. 285-288
-
-
Stephenson, M.L.1
Zamecnik, P.C.2
-
36
-
-
57849084800
-
Nucleic acids as therapeutic agents
-
Alvarez-Salas LM. Nucleic acids as therapeutic agents. Curr Top Med Chem 2008; 8: 1379-404.
-
(2008)
Curr Top Med Chem
, vol.8
, pp. 1379-1404
-
-
Alvarez-Salas, L.M.1
-
37
-
-
84865526525
-
Designing chemically modified oligonucleotides for targeted gene silencing
-
Deleavey GF, Damha MJ. Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol 2012; 19: 937-54.
-
(2012)
Chem Biol
, vol.19
, pp. 937-954
-
-
Deleavey, G.F.1
Damha, M.J.2
-
38
-
-
84856389509
-
RNA-based therapeutics: Current progress and future prospects
-
Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol 2012; 19: 60-71.
-
(2012)
Chem Biol
, vol.19
, pp. 60-71
-
-
Burnett, J.C.1
Rossi, J.J.2
-
39
-
-
61549117889
-
Nucleic acids-based therapeutics in the battle against pathogenic viruses
-
Kräusslich HG, Bartenschlager R, Eds, Berlin-Heidelberg: Springer-Verlag
-
Haasnoot J, Berkhout B. Nucleic acids-based therapeutics in the battle against pathogenic viruses. In: Kräusslich HG, Bartenschlager R, Eds. Handbook of Experimental Pharmacology. Berlin-Heidelberg: Springer-Verlag 2009; pp. 243-63.
-
(2009)
Handbook of Experimental Pharmacology
, pp. 243-263
-
-
Haasnoot, J.1
Berkhout, B.2
-
40
-
-
84879443683
-
Mipomersen sodium: First global approval
-
Hair P, Cameron F, McKeage K. Mipomersen sodium: first global approval. Drugs 2013; 73: 487-93.
-
(2013)
Drugs
, vol.73
, pp. 487-493
-
-
Hair, P.1
Cameron, F.2
McKeage, K.3
-
41
-
-
28444469246
-
Silencing of microRNAs in vivo with 'antagomirs'
-
Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-9.
-
(2005)
Nature
, vol.438
, pp. 685-689
-
-
Krützfeldt, J.1
Rajewsky, N.2
Braich, R.3
-
42
-
-
48249098902
-
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM
-
Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3: e2236.
-
(2008)
PLoS One
, vol.3
-
-
Fontana, L.1
Fiori, M.E.2
Albini, S.3
-
43
-
-
77950665077
-
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
-
Ma L, Reinhardt F, Pan E, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Bio-technol 2010; 28: 341-7.
-
(2010)
Nat Bio-technol
, vol.28
, pp. 341-347
-
-
Ma, L.1
Reinhardt, F.2
Pan, E.3
-
44
-
-
84890421450
-
Bifunctional oligodeoxynucleotide/antagomiR constructs: Evaluation of a new tool for microRNA silencing
-
Ziegler S, Eberle ME, Wölfle SJ, Heeg K, Bekeredjian-Ding I. Bifunctional oligodeoxynucleotide/antagomiR constructs: evaluation of a new tool for microRNA silencing. Nucleic Acid Ther 2013; 23: 427-34.
-
(2013)
Nucleic Acid Ther
, vol.23
, pp. 427-434
-
-
Ziegler, S.1
Eberle, M.E.2
Wölfle, S.J.3
Heeg, K.4
Bekeredjian-Ding, I.5
-
45
-
-
40249104566
-
The utility of LNA in microRNA-based cancer diagnostics and therapeutics
-
Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 2008; 18: 89-102.
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 89-102
-
-
Stenvang, J.1
Silahtaroglu, A.N.2
Lindow, M.3
Elmen, J.4
Kauppinen, S.5
-
46
-
-
40249106014
-
Antagonism of mi-croRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
-
Elmén J, Lindow M, Silahtaroglu A, et al. Antagonism of mi-croRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36: 1153-62.
-
(2008)
Nucleic Acids Res
, vol.36
, pp. 1153-1162
-
-
Elmén, J.1
Lindow, M.2
Silahtaroglu, A.3
-
47
-
-
42249093319
-
LNA-mediated microRNA silencing in non-human primates
-
Elmén J, Lindow M, Schütz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-9.
-
(2008)
Nature
, vol.452
, pp. 896-899
-
-
Elmén, J.1
Lindow, M.2
Schütz, S.3
-
48
-
-
84869120708
-
Discovering the first microRNA-targeted drug
-
Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Biol 2012; 199: 407-12.
-
(2012)
J Cell Biol
, vol.199
, pp. 407-412
-
-
Lindow, M.1
Kauppinen, S.2
-
49
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
-
(2010)
Science
, vol.327
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
-
50
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-94.
-
(2013)
N Engl J Med
, vol.368
, pp. 1685-1694
-
-
Janssen, H.L.1
Reesink, H.W.2
Lawitz, E.J.3
-
51
-
-
79953202455
-
Silencing of microRNA families by seed-targeting tiny LNAs
-
Obad S, dos Santos CO, Petri A, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011; 43: 371-8.
-
(2011)
Nat Genet
, vol.43
, pp. 371-378
-
-
Obad, S.1
dos Santos, C.O.2
Petri, A.3
-
52
-
-
35348914716
-
Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430
-
Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 2007; 318: 271-4.
-
(2007)
Science
, vol.318
, pp. 271-274
-
-
Choi, W.Y.1
Giraldez, A.J.2
Schier, A.F.3
-
53
-
-
79952201745
-
The principles of MiRNA-masking antisense oligonucleotides technology
-
Wang Z. The principles of MiRNA-masking antisense oligonucleotides technology. Methods Mol Biol 2011; 676: 43-9.
-
(2011)
Methods Mol Biol
, vol.676
, pp. 43-49
-
-
Wang, Z.1
-
54
-
-
78149303249
-
MicroRNA sponges: Progress and possibilities
-
Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010; 16: 2043-50.
-
(2010)
RNA
, vol.16
, pp. 2043-2050
-
-
Ebert, M.S.1
Sharp, P.A.2
-
55
-
-
84875372911
-
Natural RNA circles function as efficient microRNA sponges
-
Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384-8.
-
(2013)
Nature
, vol.495
, pp. 384-388
-
-
Hansen, T.B.1
Jensen, T.I.2
Clausen, B.H.3
-
56
-
-
54749089002
-
Small-molecule inhibitors of microrna miR-21 function
-
Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008; 47: 7482-84.
-
(2008)
Angew Chem Int Ed Engl
, vol.47
, pp. 7482-7484
-
-
Gumireddy, K.1
Young, D.D.2
Xiong, X.3
Hogenesch, J.B.4
Huang, Q.5
Deiters, A.6
-
57
-
-
84874640802
-
Viral vectors: A look back and ahead on gene transfer technology
-
Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M. Viral vectors: a look back and ahead on gene transfer technology. New Microbiol 2013; 36: 1-22.
-
(2013)
New Microbiol
, vol.36
, pp. 1-22
-
-
Vannucci, L.1
Lai, M.2
Chiuppesi, F.3
Ceccherini-Nelli, L.4
Pistello, M.5
-
58
-
-
66449136951
-
Therapeutic mi-croRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic mi-croRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-17.
-
(2009)
Cell
, vol.137
, pp. 1005-1017
-
-
Kota, J.1
Chivukula, R.R.2
O'Donnell, K.A.3
-
60
-
-
84878773916
-
siRNA delivery: From basics to therapeutic applications
-
Musacchio T, Torchilin VP. siRNA delivery: from basics to therapeutic applications. Front Biosci (Landmark Ed) 2013; 18: 58-79.
-
(2013)
Front Biosci (Landmark Ed)
, vol.18
, pp. 58-79
-
-
Musacchio, T.1
Torchilin, V.P.2
-
61
-
-
74149083873
-
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes
-
Takeshita F, Patrawala L, Osaki M, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010; 18: 181-7.
-
(2010)
Mol Ther
, vol.18
, pp. 181-187
-
-
Takeshita, F.1
Patrawala, L.2
Osaki, M.3
-
62
-
-
77957585971
-
Telomeres and Telomerase: The Means to the End
-
Blackburn EH. Telomeres and Telomerase: The Means to the End. Angew Chem Int Ed Engl 2010; 49: 7405-21.
-
(2010)
Angew Chem Int Ed Engl
, vol.49
, pp. 7405-7421
-
-
Blackburn, E.H.1
-
63
-
-
84860456242
-
Removal of shelterin reveals the telomere end-protection problem
-
Sfeir A, de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 2012; 336: 593-7.
-
(2012)
Science
, vol.336
, pp. 593-597
-
-
Sfeir, A.1
de Lange, T.2
-
64
-
-
81355150876
-
Telomere protection by TPP1/POT1 requires tethering to TIN2
-
Takai KK, Kibe T, Donigian JR, Frescas D, de Lange T. Telomere protection by TPP1/POT1 requires tethering to TIN2. Mol Cell 2011; 44: 647-59.
-
(2011)
Mol Cell
, vol.44
, pp. 647-659
-
-
Takai, K.K.1
Kibe, T.2
Donigian, J.R.3
Frescas, D.4
de Lange, T.5
-
65
-
-
84878769356
-
Coordinated interactions of multiple POT1-TPP1 proteins with telomere DNA
-
Corriveau M, Mullins MR, Baus D, Harris ME, Taylor DJ. Coordinated interactions of multiple POT1-TPP1 proteins with telomere DNA. J Biol Chem 2013; 288: 16361-70.
-
(2013)
J Biol Chem
, vol.288
, pp. 16361-16370
-
-
Corriveau, M.1
Mullins, M.R.2
Baus, D.3
Harris, M.E.4
Taylor, D.J.5
-
66
-
-
84871261880
-
Human Rap1 interacts directly with te-lomeric DNA and regulates TRF2 localization at the telomere
-
Arat NÖ, Griffith JD. Human Rap1 interacts directly with te-lomeric DNA and regulates TRF2 localization at the telomere. J Biol Chem 2012; 287: 41583-94.
-
(2012)
J Biol Chem
, vol.287
, pp. 41583-41594
-
-
Arat, N.Ö.1
Griffith, J.D.2
-
67
-
-
77649180958
-
Telomeres: Protecting chromosomes against genome instability
-
O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 2010; 11: 171-81.
-
(2010)
Nat Rev Mol Cell Biol
, vol.11
, pp. 171-181
-
-
O'Sullivan, R.J.1
Karlseder, J.2
-
68
-
-
84880330905
-
Tankyrases as drug targets
-
Lehtiö L, Chi NW, Krauss S. Tankyrases as drug targets. FEBS J 2013; 280: 3576-93.
-
(2013)
FEBS J
, vol.280
, pp. 3576-3593
-
-
Lehtiö, L.1
Chi, N.W.2
Krauss, S.3
-
70
-
-
77956004209
-
Apollo-taking the lead in telomere protection
-
Sharty JF, Baumann P. Apollo-taking the lead in telomere protection. Mol Cell 2010; 39: 489-91.
-
(2010)
Mol Cell
, vol.39
, pp. 489-491
-
-
Sharty, J.F.1
Baumann, P.2
-
71
-
-
0034597794
-
Telomere states and cell fates
-
Blackburn EH. Telomere states and cell fates. Nature 2000; 408: 53-6.
-
(2000)
Nature
, vol.408
, pp. 53-56
-
-
Blackburn, E.H.1
-
72
-
-
82755192899
-
Role of telomeres and telomerase in cancer
-
Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011; 21: 349-53.
-
(2011)
Semin Cancer Biol
, vol.21
, pp. 349-353
-
-
Shay, J.W.1
Wright, W.E.2
-
74
-
-
0031010342
-
A survey of telomerase activity in human cancer
-
Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-91.
-
(1997)
Eur J Cancer
, vol.33
, pp. 787-791
-
-
Shay, J.W.1
Bacchetti, S.2
-
75
-
-
84879918842
-
Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme
-
Hukezalie KR, Wong JM. Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme. FEBS J 2013; 280: 3194-204.
-
(2013)
FEBS J
, vol.280
, pp. 3194-3204
-
-
Hukezalie, K.R.1
Wong, J.M.2
-
76
-
-
58149502680
-
Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity
-
Berger W, Steiner E, Grusch M, Elbling L, Micksche M. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci 2009; 66: 43-61.
-
(2009)
Cell Mol Life Sci
, vol.66
, pp. 43-61
-
-
Berger, W.1
Steiner, E.2
Grusch, M.3
Elbling, L.4
Micksche, M.5
-
77
-
-
77951133257
-
Alternative lengthening of telomeres: Models, mechanisms and implications
-
Cesare AJ, Reddel RR. Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 2010; 11: 319-30.
-
(2010)
Nat Rev Genet
, vol.11
, pp. 319-330
-
-
Cesare, A.J.1
Reddel, R.R.2
-
78
-
-
77955846020
-
Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers
-
Henson JD, Reddel RR. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett 2010; 584: 3800-11.
-
(2010)
FEBS Lett
, vol.584
, pp. 3800-3811
-
-
Henson, J.D.1
Reddel, R.R.2
-
79
-
-
0034998040
-
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells
-
Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 2001; 21: 3862-75.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 3862-3875
-
-
Perrem, K.1
Colgin, L.M.2
Neumann, A.A.3
Yeager, T.R.4
Reddel, R.R.5
-
80
-
-
84862232995
-
Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: Expression and prognostic relevance
-
Venturini L, Daidone MG, Motta R, et al. Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance. Neuro Oncol 2012; 14: 736-44.
-
(2012)
Neuro Oncol
, vol.14
, pp. 736-744
-
-
Venturini, L.1
Daidone, M.G.2
Motta, R.3
-
81
-
-
80051560666
-
Telomere maintenance in Wilms tumors: First evidence for the presence of alternative lengthening of telomeres mechanism
-
Venturini L, Daidone MG, Motta R, et al. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism. Genes Chromosomes Cancer 2011; 50: 823-9.
-
(2011)
Genes Chromosomes Cancer
, vol.50
, pp. 823-829
-
-
Venturini, L.1
Daidone, M.G.2
Motta, R.3
-
82
-
-
84872298150
-
Alternative lengthening of telomeres in normal mammalian somatic cells
-
Neumann AA, Watson CM, Noble JR, Pickett HA, Tam PP, Red-del RR. Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev 2013; 27: 18-23.
-
(2013)
Genes Dev
, vol.27
, pp. 18-23
-
-
Neumann, A.A.1
Watson, C.M.2
Noble, J.R.3
Pickett, H.A.4
Tam, P.P.5
Red-Del, R.R.6
-
83
-
-
84858750992
-
Regulation of the human catalytic subunit of telomerase (hTERT)
-
Daniel M, Peek GW, Tollefsbol TO. Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012; 498: 135-46.
-
(2012)
Gene
, vol.498
, pp. 135-146
-
-
Daniel, M.1
Peek, G.W.2
Tollefsbol, T.O.3
-
84
-
-
24744436980
-
Lack of telom-erase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters
-
Atkinson SP, Hoare SF, Glasspool RM, Keith WN. Lack of telom-erase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 2005; 65: 7585-90.
-
(2005)
Cancer Res
, vol.65
, pp. 7585-7590
-
-
Atkinson, S.P.1
Hoare, S.F.2
Glasspool, R.M.3
Keith, W.N.4
-
85
-
-
79953311697
-
Medical genetics and epigenetics of telomerase
-
Koziel JE, Fox MJ, Steding CE, Sprouse AA, Herbert BS. Medical genetics and epigenetics of telomerase. J Cell Mol Med 2011; 15: 457-67.
-
(2011)
J Cell Mol Med
, vol.15
, pp. 457-467
-
-
Koziel, J.E.1
Fox, M.J.2
Steding, C.E.3
Sprouse, A.A.4
Herbert, B.S.5
-
86
-
-
84877748662
-
The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis
-
Listerman I, Sun J, Gazzaniga FS, Lukas JL, Blackburn EH. The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res 2013; 73: 2817-28.
-
(2013)
Cancer Res
, vol.73
, pp. 2817-2828
-
-
Listerman, I.1
Sun, J.2
Gazzaniga, F.S.3
Lukas, J.L.4
Blackburn, E.H.5
-
87
-
-
80052434889
-
Human telomerase activity regulation
-
Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep 2011; 38: 3339-49.
-
(2011)
Mol Biol Rep
, vol.38
, pp. 3339-3349
-
-
Wojtyla, A.1
Gladych, M.2
Rubis, B.3
-
88
-
-
84873170179
-
Telomerase and the search for the end of cancer
-
Mocellin S, Pooley KA, Nitti D. Telomerase and the search for the end of cancer. Trends Mol Med 2013; 19: 125-33.
-
(2013)
Trends Mol Med
, vol.19
, pp. 125-133
-
-
Mocellin, S.1
Pooley, K.A.2
Nitti, D.3
-
90
-
-
34447559500
-
Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference
-
Jiang WQ, Zhong ZH, Henson JD, Reddel RR. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 2007; 26: 4635-47.
-
(2007)
Oncogene
, vol.26
, pp. 4635-4647
-
-
Jiang, W.Q.1
Zhong, Z.H.2
Henson, J.D.3
Reddel, R.R.4
-
91
-
-
35748968799
-
Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres
-
Zhong ZH, Jiang WQ, Cesare AJ, Neumann AA, Wadhwa R, Reddel RR. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J Biol Chem 2007; 282: 29314-22.
-
(2007)
J Biol Chem
, vol.282
, pp. 29314-29322
-
-
Zhong, Z.H.1
Jiang, W.Q.2
Cesare, A.J.3
Neumann, A.A.4
Wadhwa, R.5
Reddel, R.R.6
-
92
-
-
34447129654
-
The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins
-
Potts PR, Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol 2007; 14: 581-90.
-
(2007)
Nat Struct Mol Biol
, vol.14
, pp. 581-590
-
-
Potts, P.R.1
Yu, H.2
-
93
-
-
0033519630
-
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids
-
Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL, Reddel RR. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 1999; 18: 3383-90.
-
(1999)
Oncogene
, vol.18
, pp. 3383-3390
-
-
Perrem, K.1
Bryan, T.M.2
Englezou, A.3
Hackl, T.4
Moy, E.L.5
Reddel, R.R.6
-
94
-
-
36749043110
-
Alternative lengthening of telomeres (ALT) and chromatin: Is there a connection?
-
Nittis T, Guittat L, Stewart SA. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection? Biochimie 2008; 90: 5-12.
-
(2008)
Biochimie
, vol.90
, pp. 5-12
-
-
Nittis, T.1
Guittat, L.2
Stewart, S.A.3
-
95
-
-
79960700556
-
Altered telomeres in tumors with ATRX and DAXX mutations
-
Heaphy CM, de Wilde RF, Jiao Y, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011; 333: 425.
-
(2011)
Science
, vol.333
, pp. 425
-
-
Heaphy, C.M.1
de Wilde, R.F.2
Jiao, Y.3
-
96
-
-
84864619205
-
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway
-
Lovejoy CA, Li W, Reisenweber S, et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 2012; 8: e1002772.
-
(2012)
PLoS Genet
, vol.8
-
-
Lovejoy, C.A.1
Li, W.2
Reisenweber, S.3
-
97
-
-
38949168082
-
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
-
Mitomo S, Maesawa C, Ogasawara S, et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 2008; 99: 280-6.
-
(2008)
Cancer Sci
, vol.99
, pp. 280-286
-
-
Mitomo, S.1
Maesawa, C.2
Ogasawara, S.3
-
98
-
-
84877920467
-
miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo
-
Chakrabarti M, Banik NL, Ray SK. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Exp Cell Res 2013; 319: 1575-85.
-
(2013)
Exp Cell Res
, vol.319
, pp. 1575-1585
-
-
Chakrabarti, M.1
Banik, N.L.2
Ray, S.K.3
-
99
-
-
84957556436
-
miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase
-
Chen L, Lu MH, Zhang D, et al. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis 2014; 5: e1034.
-
(2014)
Cell Death Dis
, vol.5
-
-
Chen, L.1
Lu, M.H.2
Zhang, D.3
-
100
-
-
84895870697
-
Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway
-
Hrdličková R, Nehyba J, Bargmann W, Bose HR Jr. Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway. PLoS One 2014; 9: e86990.
-
(2014)
PLoS One
, vol.9
-
-
Hrdličková, R.1
Nehyba, J.2
Bargmann, W.3
Bose, H.R.4
-
101
-
-
63749117559
-
A noncoding RNA gene on chromosome 10p15. 3 may function upstream of hTERT
-
Miura N, Sato R, Tsukamoto T, et al. A noncoding RNA gene on chromosome 10p15. 3 may function upstream of hTERT. BMC Mol Biol 2009; 10: 5.
-
(2009)
BMC Mol Biol
, vol.10
, pp. 5
-
-
Miura, N.1
Sato, R.2
Tsukamoto, T.3
-
102
-
-
84865291603
-
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma
-
Romilda C, Marika P, Alessandro S, et al. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer 2012; 12: 177.
-
(2012)
BMC Cancer
, vol.12
, pp. 177
-
-
Romilda, C.1
Marika, P.2
Alessandro, S.3
-
103
-
-
85027922313
-
The role of mi-croRNA-150 as a tumor suppressor in malignant lymphoma
-
Watanabe A, Tagawa H, Yamashita J, et al. The role of mi-croRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011; 25: 1324-34.
-
(2011)
Leukemia
, vol.25
, pp. 1324-1334
-
-
Watanabe, A.1
Tagawa, H.2
Yamashita, J.3
-
104
-
-
77956921020
-
MicroRNA-21: From cancer to cardiovascular disease
-
Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010; 11: 926-35.
-
(2010)
Curr Drug Targets
, vol.11
, pp. 926-935
-
-
Jazbutyte, V.1
Thum, T.2
-
105
-
-
84865737617
-
MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth
-
Wang YY, Sun G, Luo H, et al. MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. CNS Neurosci Ther 2012; 18: 722-8.
-
(2012)
CNS Neurosci Ther
, vol.18
, pp. 722-728
-
-
Wang, Y.Y.1
Sun, G.2
Luo, H.3
-
106
-
-
84877798880
-
High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan
-
Dellago H, Preschitz-Kammerhofer B, Terlecki-Zaniewicz L, et al. High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell 2013; 12: 446-58.
-
(2013)
Aging Cell
, vol.12
, pp. 446-458
-
-
Dellago, H.1
Preschitz-Kammerhofer, B.2
Terlecki-Zaniewicz, L.3
-
107
-
-
84870328638
-
1, 25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498
-
Kasiappan R, Shen Z, Tse AK, et al. 1, 25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. J Biol Chem 2012; 287: 41297-309.
-
(2012)
J Biol Chem
, vol.287
, pp. 41297-41309
-
-
Kasiappan, R.1
Shen, Z.2
Tse, A.K.3
-
108
-
-
77949352905
-
Telomere shortening sensitizes cancer cells to selected cytotoxic agents: In vitro and in vivo studies and putative mechanisms
-
Uziel O, Beery E, Dronichev V, et al. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms. PLoS One 2010; 5: e9132.
-
(2010)
PLoS One
, vol.5
-
-
Uziel, O.1
Beery, E.2
Dronichev, V.3
-
109
-
-
83855165805
-
MicroRNAs as a novel cellular senescence regulator
-
Liu FJ, Wen T, Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev 2012; 11: 41-50.
-
(2012)
Ageing Res Rev
, vol.11
, pp. 41-50
-
-
Liu, F.J.1
Wen, T.2
Liu, L.3
-
110
-
-
69249228684
-
Stepwise up-regulation of mi-croRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts
-
Maes OC, Sarojini H, Wang E. Stepwise up-regulation of mi-croRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol 2009; 221: 109-19.
-
(2009)
J Cell Physiol
, vol.221
, pp. 109-119
-
-
Maes, O.C.1
Sarojini, H.2
Wang, E.3
-
111
-
-
77958517467
-
MiRNA Profile Associated with Replicative Senescence, Extended Cell Culture, and Ectopic Telomerase Expression in Human Foreskin Fibroblasts
-
Bonifacio LN, Jarstfer MB. MiRNA Profile Associated with Replicative Senescence, Extended Cell Culture, and Ectopic Telomerase Expression in Human Foreskin Fibroblasts. PLoS One 2010; 5: e12519.
-
(2010)
PLoS One
, vol.5
-
-
Bonifacio, L.N.1
Jarstfer, M.B.2
-
112
-
-
80054082076
-
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region
-
Yoon AR, Gao R, Kaul Z, et al. MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Res 2011; 39: 8078-91.
-
(2011)
Nucleic Acids Res
, vol.39
, pp. 8078-8091
-
-
Yoon, A.R.1
Gao, R.2
Kaul, Z.3
-
113
-
-
40949100837
-
A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases
-
Benetti R, Gonzalo S, Jaco I, et al. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 2008; 15: 268-79.
-
(2008)
Nat Struct Mol Biol
, vol.15
, pp. 268-279
-
-
Benetti, R.1
Gonzalo, S.2
Jaco, I.3
-
114
-
-
84899984980
-
Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks
-
Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, Reli-ene R. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog 2014; 53: 458-70.
-
(2014)
Mol Carcinog
, vol.53
, pp. 458-470
-
-
Shirode, A.B.1
Kovvuru, P.2
Chittur, S.V.3
Henning, S.M.4
Heber, D.5
Reli-Ene, R.6
-
115
-
-
84863070560
-
A functional polymorphism at mi-croRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population
-
Yang L, Li Y, Cheng M, et al. A functional polymorphism at mi-croRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis 2012; 33: 338-47.
-
(2012)
Carcinogenesis
, vol.33
, pp. 338-347
-
-
Yang, L.1
Li, Y.2
Cheng, M.3
-
116
-
-
84877104492
-
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas
-
Castro-Vega LJ, Jouravleva K, Liu WY, et al. Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas. Carcinogenesis 2013; 34: 1173-80.
-
(2013)
Carcinogenesis
, vol.34
, pp. 1173-1180
-
-
Castro-Vega, L.J.1
Jouravleva, K.2
Liu, W.Y.3
-
117
-
-
77955497665
-
The role of the miR-200 family in epithelial-mesenchymal transition
-
Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 2010; 10: 219-22.
-
(2010)
Cancer Biol Ther
, vol.10
, pp. 219-222
-
-
Mongroo, P.S.1
Rustgi, A.K.2
-
118
-
-
84883272144
-
Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer
-
Roh JI, Sung YH, Lee HW. Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer. Onco Targets Ther 2013; 6: 1161-66.
-
(2013)
Onco Targets Ther
, vol.6
, pp. 1161-1166
-
-
Roh, J.I.1
Sung, Y.H.2
Lee, H.W.3
-
119
-
-
0037426088
-
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
-
Hakin-Smith V, Jellinek DA, Levy D, et al. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 2003; 361: 836-8.
-
(2003)
Lancet
, vol.361
, pp. 836-838
-
-
Hakin-Smith, V.1
Jellinek, D.A.2
Levy, D.3
-
120
-
-
0344837710
-
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma
-
Ulaner GA, Huang HY, Otero J, et al. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 2003; 63: 1759-63.
-
(2003)
Cancer Res
, vol.63
, pp. 1759-1763
-
-
Ulaner, G.A.1
Huang, H.Y.2
Otero, J.3
-
121
-
-
33748989558
-
Telomere maintenance mechanisms in liposarcomas: Association with histologic subtypes and disease progression
-
Costa A, Daidone MG, Daprai L, et al. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 2006; 66: 8918-24.
-
(2006)
Cancer Res
, vol.66
, pp. 8918-8924
-
-
Costa, A.1
Daidone, M.G.2
Daprai, L.3
-
122
-
-
48249115626
-
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma
-
Villa R, Daidone MG, Motta R, et al. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res 2008; 14: 4134-40.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4134-4140
-
-
Villa, R.1
Daidone, M.G.2
Motta, R.3
-
123
-
-
35148815673
-
Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms
-
Johnson JE, Gettings EJ, Schwalm J, et al. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms. Cancer Res 2007; 67: 9221-8.
-
(2007)
Cancer Res
, vol.67
, pp. 9221-9228
-
-
Johnson, J.E.1
Gettings, E.J.2
Schwalm, J.3
-
124
-
-
33746706757
-
Detection of telomerase activity by the TRAP assay and its variants and alternatives
-
Fajkus J. Detection of telomerase activity by the TRAP assay and its variants and alternatives. Clin Chim Acta 2006; 371: 25-31.
-
(2006)
Clin Chim Acta
, vol.371
, pp. 25-31
-
-
Fajkus, J.1
-
125
-
-
42549121200
-
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies
-
Jeyapalan JN, Mendez-Bermudez A, Zaffaroni N, Dubrova YE, Royle NJ. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Int J Cancer 2008; 122: 2414-21.
-
(2008)
Int J Cancer
, vol.122
, pp. 2414-2421
-
-
Jeyapalan, J.N.1
Mendez-Bermudez, A.2
Zaffaroni, N.3
Dubrova, Y.E.4
Royle, N.J.5
-
126
-
-
71849088980
-
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
-
Henson JD, Cao Y, Huschtscha LI, et al. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol 2009; 27: 1181-85.
-
(2009)
Nat Biotechnol
, vol.27
, pp. 1181-1185
-
-
Henson, J.D.1
Cao, Y.2
Huschtscha, L.I.3
|